Efficacy of Brentuximab vedotin in patients with Hodgkin's lymphoma relapsed after autologous peripheral blood stem-cell transplantation
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2015 New trial record